1,025 followers
Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis https://t.co/rIWqrDfy65 via @BioMedCentral #OpenAccess
Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis https://t.co/rIWqrDfy65 via @BioMedCentral #OpenAccess